These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11092066)

  • 1. Comparative efficacy of 24-hour and 16-hour transdermal nicotine patches for relief of morning craving.
    Shiffman S; Elash CA; Paton SM; Gwaltney CJ; Paty JA; Clark DB; Liu KS; Di Marino ME
    Addiction; 2000 Aug; 95(8):1185-95. PubMed ID: 11092066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep.
    Aubin HJ; Luthringer R; Demazières A; Dupont C; Lagrue G
    Nicotine Tob Res; 2006 Apr; 8(2):193-201. PubMed ID: 16766412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the nicotine patch for relief of craving and withdrawal 7-10 weeks after cessation.
    Shiffman S; Khayrallah M; Nowak R
    Nicotine Tob Res; 2000 Nov; 2(4):371-8. PubMed ID: 11197318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment.
    Schnoll RA; Martinez E; Tatum KL; Glass M; Bernath A; Ferris D; Reynolds P
    Addict Behav; 2011; 36(1-2):144-7. PubMed ID: 20869812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers.
    DeVeaugh-Geiss AM; Chen LH; Kotler ML; Ramsay LR; Durcan MJ
    Clin Ther; 2010 Jun; 32(6):1140-8. PubMed ID: 20637967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
    Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
    JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
    Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG
    Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study.
    Daughton DM; Heatley SA; Prendergast JJ; Causey D; Knowles M; Rolf CN; Cheney RA; Hatlelid K; Thompson AB; Rennard SI
    Arch Intern Med; 1991 Apr; 151(4):749-52. PubMed ID: 2012458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double-blind randomized study controlled with placebo].
    Daughton DM; Heatley SA; Prendergast JJ; Causey D; Knowles M; Rolf CN; Cheney RA; Hatlelid K; Thompson AB; De Blasio F
    Arch Monaldi Mal Torace; 1992; 47(1-6):17-29. PubMed ID: 1306633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
    Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
    JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation.
    Wallström M; Nilsson F; Hirsch JM
    Addiction; 2000 Aug; 95(8):1161-71. PubMed ID: 11092064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of naltrexone for smoking cessation.
    Wong GY; Wolter TD; Croghan GA; Croghan IT; Offord KP; Hurt RD
    Addiction; 1999 Aug; 94(8):1227-37. PubMed ID: 10615738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes.
    Schnoll RA; Hitsman B; Blazekovic S; Veluz-Wilkins A; Wileyto EP; Leone FT; Audrain-McGovern JE
    Drug Alcohol Depend; 2016 Aug; 165():245-52. PubMed ID: 27372219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain.
    Jorenby DE; Hatsukami DK; Smith SS; Fiore MC; Allen S; Jensen J; Baker TB
    Psychopharmacology (Berl); 1996 Nov; 128(2):130-8. PubMed ID: 8956374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of instructions on responses to the nicotine patch: a laboratory study.
    Fucito LM; Juliano LM
    Psychopharmacology (Berl); 2007 Nov; 194(4):475-83. PubMed ID: 17619862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.